GSA Capital Partners’s Zevra Therapeutics ZVRA Stock Holding History

GSA Capital Partners’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$517K	Buy
2022 Q4	–	Sell
2022 Q3	$126K	Buy
2022 Q2	$73K	Sell
2022 Q1	$422K	Buy